Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03990311 · ClinicalTrials.gov registry record · NA
Prepared Meals to Prime and Perpetuate Reduced Dietary Sodium Intake in Hemodialysis
A NA study of Fluid Overload in Dialysis Patients and Hypertension in Dialysis Patients, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03990311: Completed NA study of Fluid Overload in Dialysis Patients and Hypertension in Dialysis Patients, sponsored by Tufts Medical Center.
NCT03990311 is a NA study of Fluid Overload in Dialysis Patients and Hypertension in Dialysis Patients that has completed, run by Tufts Medical Center. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03990311, a NA study of Fluid Overload in Dialysis Patients and Hypertension in Dialysis Patients, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized clinical trial in which maintenance hemodialysis patients will be provided with salt restricted 'dialysis friendly' meals and compared to a control arm receiving usual care.
Primary Outcome
A standard measurement taken for HD patients at each dialysis session to see weight gained between sessions
Conditions Studied
Interventions
- OTHER Control
- OTHER Sodium Restricted Meals
Study Locations (1)
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT03990311 record still lists
NCT03990311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Fluid Overload in Dialysis Patients appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03990311 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03990311 about?
NCT03990311 is a clinical study titled "Prepared Meals to Prime and Perpetuate Reduced Dietary Sodium Intake in Hemodialysis". This is a randomized clinical trial in which maintenance hemodialysis patients will be provided with salt restricted 'dialysis friendly' meals and compared to a control arm receiving usual care.
What is the current status of trial NCT03990311?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-06-05. Estimated completion is 2021-12-31.
What conditions does trial NCT03990311 study?
This clinical trial studies the following conditions: Fluid Overload in Dialysis Patients, Hypertension in Dialysis Patients.
What interventions are being tested in trial NCT03990311?
The interventions under investigation include: Control (OTHER), Sodium Restricted Meals (OTHER).
Who is sponsoring clinical trial NCT03990311?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03990311 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fluid Overload in Dialysis Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03990311's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI